After a friend died of breast cancer at age 34, Isaac Harris, Ph.D., felt the urgency of his work to better understand how cancer cells grow and resist treatment.
A family history of cancer pushed Rachael Turner, M.D., Ph.D., into an oncology career, where she’s studying an ovarian cancer biomarker, HE4.
Ian Kleckner, Ph.D., M.P.H., has always found the mind-body connection fascinating, and today, his work focuses on discovering whether exercise may help with a common cancer treatment side effect: ...
Michael Giacomelli, Ph.D., has two babies: His daughter, born just as he was setting up his lab in Rochester, and a prized invention, a novel 3D imaging device that helps surgeons detect whether a ...
Ben Frisch, Ph.D., grew up on a dairy farm and is no stranger to hard work. As a researcher, he’s working to understand how cancer impacts healthy bone marrow.
His interest in science started at a young age, and today Thomas Ciucci, Ph.D., wants to better understand T-cells, in hopes of making them better fighters against cancer.
Paul Boutz, Ph.D., thought he’d be a paleontologist until he studied under a prominent RNA biologist and shifted his course toward cancer biology.
Brian Altman, Ph.D., began his career studying circadian rhythms, but after losing a family member to lung cancer, his work shifted its focus.
Despite humble beginnings, today, Jeevisha Bajaj, Ph.D., uses some of the most sophisticated tools – including CRISPR technology – to study blood cancers.
As part of an academic medical center, Wilmot Cancer Institute has a responsibility to develop the next generation of physicians and researchers and to help shape the ever-evolving landscape of ...